These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3094437)

  • 1. Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Antimicrob Agents Chemother; 1986 Aug; 30(2):258-9. PubMed ID: 3094437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria.
    Eliopoulos GM; Reiszner E; Caputo GM; Moellering RC
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):341-4. PubMed ID: 3096629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal effect and regrowth of Streptococcus faecalis exposed to amoxicillin following beta-lactamase.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crockaert F; Glupczynski Y
    Chemotherapy; 1988; 34(6):462-6. PubMed ID: 3149569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
    Peiffer-Smadja N; Guillotel E; Luque-Paz D; Maataoui N; Lescure FX; Cattoir V
    J Antimicrob Chemother; 2019 Dec; 74(12):3511-3514. PubMed ID: 31495901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
    Kim MJ; Weiser M; Gottschall S; Randall EL
    J Clin Microbiol; 1987 May; 25(5):787-90. PubMed ID: 3108309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2.
    Bravetti AL; Mesnage S; Lefort A; Chau F; Eckert C; Garry L; Arthur M; Fantin B
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1667-9. PubMed ID: 19188384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of enterococci. I. Inhibitory and bactericidal activity of several chemoantibiotics against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):302-8. PubMed ID: 3098440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2786-9. PubMed ID: 9420061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis.
    Mainardi JL; Gutmann L; Acar JF; Goldstein FW
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1984-7. PubMed ID: 8540703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis.
    Aslangul E; Ruimy R; Chau F; Garry L; Andremont A; Fantin B
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4144-8. PubMed ID: 16189091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.
    Grohs P; Houssaye S; Aubert A; Gutmann L; Varon E
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3542-7. PubMed ID: 14576115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of enterococci. II. Inhibitory and bactericidal activity of drugs in combination against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):309-12. PubMed ID: 3098441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalis.
    Dubée V; Chau F; Arthur M; Garry L; Benadda S; Mesnage S; Lefort A; Fantin B
    Antimicrob Agents Chemother; 2011 Feb; 55(2):910-2. PubMed ID: 21098238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
    Gradelski E; Valera L; Kolek B; Bonner D; Fung-Tomc J
    Int J Antimicrob Agents; 2001 Jul; 18(1):43-8. PubMed ID: 11463525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Wise R; Andrews JM; Ashby JP; Matthews RS
    Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.
    Cohen MA; Yoder SL; Huband MD; Roland GE; Courtney CL
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2123-7. PubMed ID: 8540728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
    Aubert G; Pozzetto B; Dorche G
    Pathol Biol (Paris); 1991 Dec; 39(10):1006-8. PubMed ID: 1666668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.